Related Experiment Video

Updated: Mar 14, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K

DRG2 Regulates G2/M Progression via the Cyclin B1-Cdk1 Complex

Soo Hwa Jang1, Ah-Ram Kim1, Neung-Hwa Park2

  • 1School of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.

Molecules and Cells
|September 28, 2016
PubMed

Insights

Developmentally regulated GTP-binding protein 2 (DRG2) is crucial for cell growth. Its knockdown causes G2/M phase arrest, impacting cell cycle progression and reducing tumor growth.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Developmentally regulated GTP-binding protein 2 (DRG2) is known to be involved in cell growth.
  • The precise role of DRG2 in regulating the cell cycle, particularly the G2/M phase checkpoint, remains largely unexplored.

Purpose of the Study:

  • To investigate the role of DRG2 in cell cycle progression.
  • To elucidate the specific mechanisms by which DRG2 influences the G2/M phase checkpoint.

Main Methods:

  • HeLa cells with DRG2 knockdown were utilized.
  • Wound-healing assays and nude mice xenografts were performed to assess growth and tumorigenicity.
  • Flow cytometry and [(3)H] incorporation assays were conducted to analyze cell proliferation and cell cycle distribution.
  • Western blotting or similar techniques were used to examine the expression levels of key cell cycle regulatory proteins.

Main Results:

  • Knockdown of DRG2 significantly impaired cell growth in wound-healing assays and reduced tumorigenicity in vivo.
  • DRG2 knockdown led to a notable G2/M phase arrest, correlating with decreased cellular proliferation.
  • The expression of the mitotic cyclin B1/Cdk1 complex was downregulated, while cell cycle inhibitors Wee1, Myt1, and p21 were upregulated following DRG2 knockdown.

Conclusions:

  • DRG2 plays a critical role in regulating the G2/M phase checkpoint.
  • DRG2 influences cell cycle progression by modulating the balance between mitotic promoting factors and cell cycle inhibitors.
  • These findings reveal a novel function for DRG2 in maintaining normal cell cycle progression and suggest its potential as a therapeutic target in cancer.
Keywords:
DRG2G2/M check pointcyclin B/Cdk1 complexp21

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.5K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K